Delivery Order SPE2DB20D3103-SPE2DB24FM2M4

Award Date 1/11/24
Potential Completion Date 1/12/24
Potential Value $2.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,402.97 firm fixed-price delivery order is for the supply of 4564616857 - ROCURONIUM 50 MG/5 ML VIAL 5ML. The contract has a completion date of May 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,764.10, is for the delivery of Rocuronium 50 mg/5 ml vials. This is a firm fixed-price, delivery order contract with a period of performance through March 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,074.12 firm fixed-price delivery order is for the supply of 50 mg/5 mL vials of the drug rocuronium, with a completion date of May 28, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,058.23 fixed-price delivery order is for the provision of 100 mg/10 mL vials of the drug Rocuronium, a neuromuscular blocking agent used in anesthesia. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the federal government: a single-award IDC...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide ROCURONIUM 100 MG/10 ML VIAL 10ML, a pharmaceutical product, with a potential value of $3,487.20. The contract has a period of performance through February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and has no major subcontractors listed. This contract is not associated with any set-aside designation....
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of Rocuronium Bromide, a muscle relaxant medication, with a total ceiling value of $2,246.72 and a performance period through December 26, 2023. Amerisourcebergen Drug Corp has received numerous similar federal contract awards from DLA...
This is a $1,105.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567367457 ROCURONIUM 100 MG/10 ML VIAL 10ML, a critical medical commodity, to support federal healthcare programs. The award is part of AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver a range of pharmaceutical products and medical supplies to the U.S. government. The $25,547.09 Firm Fixed Price contract is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of January 16, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $76,037.00 firm fixed-price delivery order contract is for the supply of various pharmaceutical products and medical supplies to support military healthcare programs. The contract has an ultimate completion date of June 15, 2023. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed price delivery order for ROCURONIUM 100 MG/10 ML VIAL 10ML awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,317.12 delivery order is part of a larger indefinite delivery contract between Amerisourcebergen Drug Corp and the DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. The contract does not have a set-aside...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FM2M4
    Delivery Order

This federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Rocuronium 50 mg/5 ml vials. The $2,748.48 firm-fixed-price delivery order contract has a completion date of January 12, 2024.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical medical commodities. The contract award reviewed does not have a set-aside designation, indicating it was competed openly.

Generated 2/27/25, 10:31 AM